Search Results

Filter
  • 1-10 of  50 results for ""Cerebellar Neoplasms""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Heterogeneity and tumoral origin of medulloblastoma in the single-cell era.

  • Authors : Sheng H; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.; Li H

Subjects: Medulloblastoma*/Medulloblastoma*/Medulloblastoma*/genetics ; Medulloblastoma*/Medulloblastoma*/Medulloblastoma*/therapy ; Medulloblastoma*/Medulloblastoma*/Medulloblastoma*/pathology

  • Source: Oncogene [Oncogene] 2024 Mar; Vol. 43 (12), pp. 839-850. Date of Electronic Publication: 2024 Feb 14.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target.

  • Authors : Navickas SM; Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia.; Giles KA

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/genetics ; Cerebellar Neoplasms* ; DNA Helicases*/DNA Helicases*/DNA Helicases*/genetics

  • Source: Oncogene [Oncogene] 2023 Jul; Vol. 42 (31), pp. 2363-2373. Date of Electronic Publication: 2023 Jul 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis.

  • Authors : Xie W; Department of Pediatric Neurosurgery, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Wang J

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/genetics ; Ubiquitin-Protein Ligases*/Ubiquitin-Protein Ligases*/Ubiquitin-Protein Ligases*/metabolism ; Ubiquitin-Protein Ligases*/Ubiquitin-Protein Ligases*/Ubiquitin-Protein Ligases*/genetics

  • Source: Oncogene [Oncogene] 2024 May; Vol. 43 (19), pp. 1463-1475. Date of Electronic Publication: 2024 Mar 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors.

  • Authors : Di Giulio S; Department of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.; Colicchia V

Subjects: Cerebellar Neoplasms/Cerebellar Neoplasms/Cerebellar Neoplasms/*drug therapy ; Medulloblastoma/Medulloblastoma/Medulloblastoma/*drug therapy ; N-Myc Proto-Oncogene Protein/N-Myc Proto-Oncogene Protein/N-Myc Proto-Oncogene Protein/*genetics

  • Source: Oncogene [Oncogene] 2021 Oct; Vol. 40 (43), pp. 6143-6152. Date of Electronic Publication: 2021 Sep 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model.

  • Authors : Tan IL; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Biochemistry, Cell and Molecular Biology Program, Weill Graduate School of Medical Sciences of Cornell University, New York, NY, USA.

Subjects: Disease Models, Animal*; Cerebellar Neoplasms/Cerebellar Neoplasms/Cerebellar Neoplasms/*prevention & control ; Hedgehog Proteins/Hedgehog Proteins/Hedgehog Proteins/*physiology

  • Source: Oncogene [Oncogene] 2021 Jan; Vol. 40 (2), pp. 396-407. Date of Electronic Publication: 2020 Nov 06.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

BMI1 is a therapeutic target in recurrent medulloblastoma.

  • Authors : Bakhshinyan D; McMaster Stem Cell and Cancer Research Institute, McMaster University, Hamilton, ON, L8S 4L8, Canada.; Departments of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4L8, Canada.

Subjects: Cerebellar Neoplasms/Cerebellar Neoplasms/Cerebellar Neoplasms/*drug therapy ; Medulloblastoma/Medulloblastoma/Medulloblastoma/*drug therapy ; Neoplastic Stem Cells/Neoplastic Stem Cells/Neoplastic Stem Cells/*drug effects

  • Source: Oncogene [Oncogene] 2019 Mar; Vol. 38 (10), pp. 1702-1716. Date of Electronic Publication: 2018 Oct 22.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.

  • Authors : Bolin S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.; Borgenvik A

Subjects: Azepines/Azepines/Azepines/*administration & dosage ; Cerebellar Neoplasms/Cerebellar Neoplasms/Cerebellar Neoplasms/*genetics ; Medulloblastoma/Medulloblastoma/Medulloblastoma/*drug therapy

  • Source: Oncogene [Oncogene] 2018 May; Vol. 37 (21), pp. 2850-2862. Date of Electronic Publication: 2018 Mar 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.

  • Authors : Rodriguez-Blanco J; Molecular Oncology Program, The DeWitt Daughtry Family Department of Surgery, University of Miami, Miller School of Medicine, Miami, FL, USA.; Pednekar L

Subjects: Wnt Signaling Pathway*; Cerebellar Neoplasms/Cerebellar Neoplasms/Cerebellar Neoplasms/*metabolism ; Hedgehog Proteins/Hedgehog Proteins/Hedgehog Proteins/*metabolism

  • Source: Oncogene [Oncogene] 2017 Nov 09; Vol. 36 (45), pp. 6306-6314. Date of Electronic Publication: 2017 Jul 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.

  • Authors : Kawauchi D; Department of Tumor Cell Biology, St Jude Children's Research Hospital (SJCRH), Memphis, TN, USA.; Division of Pediatric Neuro-Oncology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.

Subjects: Cerebellar Neoplasms/Cerebellar Neoplasms/Cerebellar Neoplasms/*genetics ; Cerebellum/Cerebellum/Cerebellum/*embryology ; Cerebellum/Cerebellum/Cerebellum/*pathology

  • Source: Oncogene [Oncogene] 2017 Sep 14; Vol. 36 (37), pp. 5231-5242. Date of Electronic Publication: 2017 May 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.

  • Authors : Shi X; Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Wang Q

Subjects: Epigenesis, Genetic* ; Gene Expression Regulation, Neoplastic*; Cerebellar Neoplasms/Cerebellar Neoplasms/Cerebellar Neoplasms/*genetics

  • Source: Oncogene [Oncogene] 2016 Nov 03; Vol. 35 (44), pp. 5746-5758. Date of Electronic Publication: 2016 Apr 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  50 results for ""Cerebellar Neoplasms""